PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 90 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -100.0% | 22 | -99.9% | 0.00% | – |
| Q4 2022 | $29 | -100.0% | 15,716 | -93.9% | 0.00% | -100.0% |
| Q3 2022 | $663,000 | +16475.0% | 258,285 | +18012.6% | 0.00% | – |
| Q1 2022 | $4,000 | -85.2% | 1,426 | -76.9% | 0.00% | – |
| Q4 2021 | $27,000 | -85.2% | 6,184 | -75.5% | 0.00% | – |
| Q3 2021 | $182,000 | +6.4% | 25,200 | +0.3% | 0.00% | – |
| Q2 2021 | $171,000 | +2037.5% | 25,116 | +1557.8% | 0.00% | – |
| Q3 2020 | $8,000 | -87.7% | 1,515 | -87.9% | 0.00% | – |
| Q2 2020 | $65,000 | +364.3% | 12,519 | +181.1% | 0.00% | – |
| Q1 2020 | $14,000 | -89.6% | 4,453 | -86.8% | 0.00% | – |
| Q4 2019 | $135,000 | +350.0% | 33,640 | +370.1% | 0.00% | – |
| Q3 2019 | $30,000 | – | 7,156 | +22262.5% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 32 | -98.1% | 0.00% | – |
| Q4 2018 | $8,000 | -82.6% | 1,697 | -64.5% | 0.00% | – |
| Q3 2018 | $46,000 | -41.8% | 4,776 | +7.8% | 0.00% | -100.0% |
| Q4 2017 | $79,000 | -91.3% | 4,429 | -87.8% | 0.00% | -91.9% |
| Q3 2017 | $911,000 | +54.4% | 36,318 | +48.3% | 0.04% | +42.3% |
| Q2 2017 | $590,000 | – | 24,492 | +306050.0% | 0.03% | – |
| Q4 2014 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |